Dr. Carl E. Millner, MD
Internal Medicine (Internal Medicine Physician)
99 N La Cienega Blvd Ste 200
Beverly Hills, CA 90211
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Hahnemann University College of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 25
Licensed in California since 2003, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: Hahnemann University College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
CA license G81910 (first issued 2003; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Aids Healthcare Foundation (101 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 25
- Services billed
- 140
- Patients’ average age
- 65
| Service | Times | Patients |
|---|---|---|
| Insertion of needle into vein for collection of blood sample | 165 | 102 |
| Established patient office or other outpatient visit, 20-29 minutes | 100 | 74 |
| Established patient office or other outpatient visit, 30-39 minutes | 96 | 65 |
| Administration of influenza virus vaccine | 14 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Beverly Hills, CA | 203 |
| Biktarvy (bictegrav/emtricit/tenofov ala) | 115 |
| Descovy (emtricitabine/tenofov alafenam) | 105 |
| Triumeq (abacavir/dolutegravir/lamivudi) | 100 |
| Tivicay (dolutegravir sodium) | 100 |
| Lisinopril Other prescribers in Beverly Hills, CA | 90 |
| Symtuza (darunavir/cob/emtri/tenof alaf) | 89 |
| Prezcobix (darunavir/cobicistat) | 85 |
| Tamsulosin Hcl Other prescribers in Beverly Hills, CA | 84 |
| Rosuvastatin Calcium Other prescribers in Beverly Hills, CA | 82 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 10 payments worth $1,585 in total to this clinician.
| Viiv Healthcare Company | $1,496 |
|---|---|
| Theratechnologies Inc. | $88.79 |
| Travel and Lodging | $1,136 |
|---|---|
| Food and Beverage | $449 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Viiv Healthcare Company Oct 29, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $855 |
| Viiv Healthcare Company Nov 3, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $250 |
| Viiv Healthcare Company Oct 29, 2025 | Travel and Lodging travel to Chicago, IL · in-kind | $31.41 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $68,089 in research payments for these studies, mostly to the institutions running them.
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
Eli Lilly and Company · Active, not recruiting · NCT06383390 - M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of…
AbbVie Inc. - A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382
AbbVie Inc. · Terminated · NCT06032546 - Quicksilver
Becton, Dickinson and Company
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.